{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:13:34Z","timestamp":1789535614533,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study aimed to retrospectively assess the safety and efficacy of radioactive iodine-125 (I-125) seed implantation for liver malignancies in challenging locations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Between December 2015 and December 2021, 49 patients with 60 liver malignancies in challenging locations who underwent computed tomography (CT)-guided I-125 seed implantation were retrospectively analyzed. The primary endpoints included technical success rate and overall survival (OS), whereas the secondary endpoints included progression-free survival (PFS), disease control rate (DCR), objective response rate (ORR), and liver recurrence. Potential factors associated with liver recurrence were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The technical success rate was 100%. The median follow-up duration was 12 months (range, 2\u201368 months). The mean OS and PFS were 17.58 months (95% CI: 13.64\u201321.52 months) and 13.14 months (95% CI: 10.36\u201315.92 months), respectively. The 2-month, 6-month, and 1-year DCR and ORR were 97.96% and 93.88%, 93.75% and 77.08%, and 93.48% and 60.87%, respectively. The 6- and 12-month tumor recurrence rates were 20.41% and 28.26%, respectively. The Kaplan\u2013Meier method was used to estimate the time of liver recurrence, with our results showing that patients with primary intrahepatic cholangiocarcinoma had an increased likelihood of having earlier liver recurrence. No major complications developed during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>CT-guided radioactive I-125 implantation could be a safe and effective alternative with promising survival benefits and high local control rates for liver malignancies in challenging locations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2638_22","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:49:58Z","timestamp":1724932198000},"page":"1165-1172","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Computed tomography-guided radioactive iodine-125 seed implantation for liver malignancies in challenging locations"],"prefix":"10.4103","volume":"20","author":[{"given":"Lin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Operating Room, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China"},{"name":"Interventional Oncology Institute, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Interventional and Minimally Invasive Oncology, The Second Hospital of Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujian","family":"Han","sequence":"additional","affiliation":[{"name":"Interventional Oncology Institute, Shandong University, Jinan, China"},{"name":"Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Interventional and Minimally Invasive Oncology, The Second Hospital of Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunjing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Interventional Oncology Institute, Shandong University, Jinan, China"},{"name":"Dean Office, Jinan Vocational College of Nursing, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3892\/ol.2020.11765","article-title":"Enhanced therapeutic effect of transcatheter arterial chemoembolization combined with radioactive I-125 seed implantation on liver cancer","volume":"20","author":"Liu","year":"2020","journal-title":"Oncol Lett"},{"key":"R3-20241021","article-title":"Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma","volume":"31","author":"Sposito","year":"2022","journal-title":"J Hepatol"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3348\/kjr.2009.10.5.425","article-title":"The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma","volume":"10","author":"Shin","year":"2009","journal-title":"Korean J Radiol"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21037\/hbsn.2017.01.16","article-title":"Management of unresectable intrahepatic cholangiocarcinoma: How do we decide among the various liver-directed treatments?","volume":"6","author":"Koay","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12094-019-02182-z","article-title":"Multidisciplinary management of liver metastases in patients with colorectal cancer: A consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM","volume":"22","author":"Vera","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4103\/jcrt.jcrt_1252_21","article-title":"Microwave ablation combined with I125 seed implantation for treatment of residual lesions of liver cancer after TACE","volume":"18","author":"Zhang","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0034-1373789","article-title":"Complications of image-guided thermal ablation of liver and kidney neoplasms","volume":"31","author":"Kim","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2147\/JHC.S292516","article-title":"Carbon ion radiotherapy in the management of hepatocellular carcinoma","volume":"24","author":"Abousaida","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.4103\/jcrt.JCRT_629_19","article-title":"Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma","volume":"15","author":"Song","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/jcrt.jcrt_266_21","article-title":"Image fusion technique for target volume delineation in 125I seed implant brachytherapy for parotid gland cancers","volume":"18","author":"Li","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/02656736.2017.1370728","article-title":"Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: Safety and efficacy of high-power microwave platforms","volume":"34","author":"Filippiadis","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"R13-20241021","first-page":"384","article-title":"Magnetic resonance imaging-guided percutaneous cryoablation of hepatocellular carcinoma in special regions","volume":"9","author":"Wu","year":"2010","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1016\/j.jvir.2009.04.011","article-title":"Image-guided tumor ablation: Standardization of terminology and reporting criteria","volume":"20","author":"Goldberg","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijrobp.2005.08.029","article-title":"Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy","volume":"64","author":"Nag","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5114\/jcb.2020.96863","article-title":"Iodine-125 seed implantation for residual hepatocellular carcinoma or cholangiocellular carcinoma in challenging locations after transcatheter arterial chemoembolization: Initial experience and findings","volume":"12","author":"Li","year":"2020","journal-title":"J Contemp Brachytherapy"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4103\/jcrt.jcrt_519_22","article-title":"Effects of iodine-125 seed brachytherapy on patients with heterochronous pulmonary metastasis from hepatocellular carcinoma: A propensity score matching study","volume":"19","author":"Yang","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13645706.2018.1432489","article-title":"Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments","volume":"27","author":"Gnutzmann","year":"2018","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/1097-0142(19911115)68:10<2150::AID-CNCR2820681011>3.0.CO;2-F","article-title":"Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model","volume":"68","author":"Ikeda","year":"1991","journal-title":"Cancer"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jvir.2009.01.011","article-title":"Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: A single-center study","volume":"20","author":"Liu","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4103\/jcrt.jcrt_483_22","article-title":"Comparison of analgesic effect in celiac plexus neurolysis: Ethanol injection with or without iodine-125 radioactive seeds implantation","volume":"18","author":"Kong","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3748\/wjg.v21.i8.2336","article-title":"Biological effects of low-dose-rate irradiation of pancreatic carcinoma cells in vitro using 125I seeds","volume":"21","author":"Wang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ejrad.2011.03.043","article-title":"1.5T conventional MR-guided iodine-125 interstitial implants for hepatocellular carcinoma: Feasibility and preliminary clinical experience","volume":"81","author":"Lin","year":"2012","journal-title":"Eur J Radiol"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address: easloffice@easloffice.eu;European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/cld.530","article-title":"Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma","volume":"7","author":"Barman","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jhep.2017.03.007","article-title":"The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy","volume":"67","author":"Galle","year":"2017","journal-title":"J Hepatol"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"1011033","DOI":"10.3389\/fphar.2022.1011033","article-title":"The role of hypoxia-related genes in TACE-refractory hepatocellular carcinoma: Exploration of prognosis, immunological characteristics and drug resistance based on onco-multi-OMICS approach","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Pharmacol"},{"key":"R30-20241021","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8223336","article-title":"To systematically evaluate and analyze the efficacy and safety of Transcatheter Arterial Chemoembolization (TACE) in the treatment of primary liver cancer","author":"Yang","year":"2022","journal-title":"J Healthc Eng 2022"},{"key":"R31-20241021","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: A 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"R32-20241021","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/02841851003786001","article-title":"Pneumothorax induced by radiofrequency ablation for hepatocellular carcinoma beneath the diaphragm under real-time computed tomography-fluoroscopic guidance","volume":"51","author":"Miura","year":"2010","journal-title":"Acta Radiol"},{"key":"R33-20241021","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1186\/s12885-020-07261-x","article-title":"Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Cancer"},{"key":"R34-20241021","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00270-015-1094-3","article-title":"Artificial ascites for pain relief during microwave ablation of subcapsular liver tumors","volume":"38","author":"Hakim\u00e9","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R35-20241021","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4103\/jcrt.jcrt_1697_22","article-title":"Significant response to transarterial chemoembolization combined with PD-1 inhibitor and apatinib for advanced intrahepatic cholangiocarcinoma: A case report and literature review","volume":"19","author":"Zhang","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R36-20241021","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","article-title":"Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management","volume":"379","author":"Zhang","year":"2016","journal-title":"Cancer Lett"},{"key":"R37-20241021","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.3892\/or.2017.5531","article-title":"Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review)","volume":"37","author":"Al Bandar","year":"2017","journal-title":"Oncol Rep"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2638_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:17Z","timestamp":1787067737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2638_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2638_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"2022-12-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}